HM12525A

Merck scoops up a PhII J&J discard in a bargain-basement deal. And this time they’re shooting at NASH
Endpoints
Tue, 08/4/20 - 12:42 pm
Merck
JNJ
South Korea
Hanmi Pharma
HM12525A
NASH
J&J dumps Hanmi obesity drug following midphase trials
Fierce Biotech
Mon, 07/8/19 - 10:51 am
JNJ
HM12525A
obesity
Hanmi Pharmaceutical